Logotipo do repositório
 

Publicação:
Bioreactivity of a novel poly(epsilon-caprolactone) nanocapsule containing atrazine with human lung alveolar epithelial cells

dc.contributor.authorMoore, Amber J. S.
dc.contributor.authorDean, Lareb S. N.
dc.contributor.authorYam, Aiken N. K.
dc.contributor.authorde Lima, Renata
dc.contributor.authorFraceto, Leonardo F. [UNESP]
dc.contributor.authorTetley, Teresa D.
dc.contributor.institutionImperial College London
dc.contributor.institutionHealth Impact of Environmental Hazards at King's College London in partnership with Public Health England (PHE) in collaboration with Imperial College London
dc.contributor.institutionUniversity of Sorocaba
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2023-03-01T20:54:32Z
dc.date.available2023-03-01T20:54:32Z
dc.date.issued2022-04-28
dc.description.abstractAtrazine (ATZ), a commonly used agricultural herbicide, is potentially harmful to animals and humans. Nanoencapsulation of ATZ (NC-ATZ) within non-toxic, biodegradable poly(ϵ-caprolactone) (PCL) improves the herbicidal activity of ATZ 10-fold and moderates its environmental persistence, possibly reducing off-target ecological effects. These compounds may reach the pulmonary respiratory units following inhalation; thus, we investigated the effect of ATZ and NC-ATZ on an immortalised human lung alveolar type 1-like epithelial cell model (TT1 cells). The concentration-dependent effect of the compounds was analysed by assessment of viability, reactive oxygen species (ROS) production and inflammatory cytokine release. Confocal microscopy was used to visualise TT1 cell-nanoparticle interactions. NC-ATZ caused cellular effects not observed with ATZ or the PCL nanocapsule alone. NC-ATZ significantly increased lactate dehydrogenase (LDH) release at ≥1 μg ml−1 after 48 hours of exposure, peaking at 5 μg ml−1 (3-fold of the non-treated control, ***p < 0.001). Moreover, ≥1 μg ml−1 NC-ATZ was pro-inflammatory at 48 hours, peaking at 5 μg ml−1 (IL-6 release ∼125 pg ml−1; IL-8 release ∼46 pg ml−1). Confocal microscopy of fluorescently-labelled ATZ and NC-ATZ indicated high intensity fluorescence nanoparticle uptake into the cytoplasm and co-localisation in the Golgi, suggesting nanoparticle recycling within 24 hours. We provide evidence that nanoencapsulation of the pesticide ATZ alters bioreactivity, stimulating more necrosis and inflammation in human lung alveolar type 1 epithelial cells in comparison to ATZ or the PCL nanocapsule alone. However, nanoencapsulation improves the efficacy of pesticides, thus lower pesticide concentrations could be used, reducing environmental contamination. Further investigation, particularly with different exposure scenarios, is warranted in order to generate safer nanoencapsulated pesticides.en
dc.description.affiliationLung Cell Biology Airways Disease National Heart and Lung Institute Imperial College London
dc.description.affiliationThe National Institute for Health Research Health Protection Research Unit (NIHR HPRU) Health Impact of Environmental Hazards at King's College London in partnership with Public Health England (PHE) in collaboration with Imperial College London
dc.description.affiliationLABiToN − Laboratory for Evaluation of Bioactivity and Toxicology of Nanomaterials University of Sorocaba
dc.description.affiliationSão Paulo State University (UNESP) Institute of Science and Technology of Sorocaba Laboratory of Environmental Nanotechnology, Sorocaba
dc.description.affiliationUnespSão Paulo State University (UNESP) Institute of Science and Technology of Sorocaba Laboratory of Environmental Nanotechnology, Sorocaba
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipHealth Research
dc.description.sponsorshipPublic Health England
dc.description.sponsorshipUniversity of Kentucky
dc.description.sponsorshipUniverzita Karlova v Praze
dc.description.sponsorshipImperial College London
dc.format.extent2134-2148
dc.identifierhttp://dx.doi.org/10.1039/d1en01068a
dc.identifier.citationEnvironmental Science: Nano, v. 9, n. 6, p. 2134-2148, 2022.
dc.identifier.doi10.1039/d1en01068a
dc.identifier.issn2051-8161
dc.identifier.issn2051-8153
dc.identifier.scopus2-s2.0-85133388109
dc.identifier.urihttp://hdl.handle.net/11449/241270
dc.language.isoeng
dc.relation.ispartofEnvironmental Science: Nano
dc.sourceScopus
dc.titleBioreactivity of a novel poly(epsilon-caprolactone) nanocapsule containing atrazine with human lung alveolar epithelial cellsen
dc.typeArtigo
dspace.entity.typePublication
unesp.author.orcid0000-0002-8772-1745[1]
unesp.author.orcid0000-0002-8703-9236 0000-0002-8703-9236[2]
unesp.author.orcid0000-0003-0351-2522[3]
unesp.author.orcid0000-0001-8712-1144[4]
unesp.author.orcid0000-0002-2827-2038[5]
unesp.author.orcid0000-0002-1368-9586 0000-0002-1368-9586[6]
unesp.campusUniversidade Estadual Paulista (UNESP), Instituto de Ciência e Tecnologia, Sorocabapt
unesp.departmentEngenharia Ambiental - ICTSpt

Arquivos